Detalhe da pesquisa
1.
Chemotherapy de-escalation using an 18F-FDG-PET-based pathological response-adapted strategy in patients with HER2-positive early breast cancer (PHERGain): a multicentre, randomised, open-label, non-comparative, phase 2 trial.
Lancet Oncol
; 22(6): 858-871, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34019819
2.
Development and validation of a sexual relations satisfaction scale in patients with breast cancer - "SEXSAT-Q".
Health Qual Life Outcomes
; 17(1): 143, 2019 Aug 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-31420041
3.
Proteomic Analysis of the E3 Ubiquitin-Ligase Hakai Highlights a Role in Plasticity of the Cytoskeleton Dynamics and in the Proteasome System.
J Proteome Res
; 16(8): 2773-2788, 2017 08 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28675930
4.
Neoadjuvant Therapy with Weekly Nanoparticle Albumin-Bound Paclitaxel for Luminal Early Breast Cancer Patients: Results from the NABRAX Study (GEICAM/2011-02), a Multicenter, Non-Randomized, Phase II Trial, with a Companion Biomarker Analysis.
Oncologist
; 22(11): 1301-1308, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28701571
5.
Physical activity and breast cancer risk by pathological subtype.
Gynecol Oncol
; 144(3): 577-585, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28057355
6.
High Proliferation Predicts Pathological Complete Response to Neoadjuvant Chemotherapy in Early Breast Cancer.
Oncologist
; 21(2): 150-5, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26786263
7.
Prognostic ability of EndoPredict compared to research-based versions of the PAM50 risk of recurrence (ROR) scores in node-positive, estrogen receptor-positive, and HER2-negative breast cancer. A GEICAM/9906 sub-study.
Breast Cancer Res Treat
; 156(1): 81-9, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26909792
8.
Diagnostic accuracy of MRI to evaluate tumour response and residual tumour size after neoadjuvant chemotherapy in breast cancer patients.
Radiol Oncol
; 50(1): 73-9, 2016 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27069452
9.
Defining breast cancer intrinsic subtypes by quantitative receptor expression.
Oncologist
; 20(5): 474-82, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25908555
10.
Standard versus continuous administration of capecitabine in metastatic breast cancer (GEICAM/2009-05): a randomized, noninferiority phase II trial with a pharmacogenetic analysis.
Oncologist
; 20(2): 111-2, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25601966
11.
Circulating miR-200c and miR-141 and outcomes in patients with breast cancer.
BMC Cancer
; 15: 297, 2015 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-25885099
12.
Clinical validation of the EndoPredict test in node-positive, chemotherapy-treated ER+/HER2- breast cancer patients: results from the GEICAM 9906 trial.
Breast Cancer Res
; 16(2): R38, 2014 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-24725534
13.
Circulating levels of GDF15, MMP7 and miR-200c as a poor prognostic signature in gastric cancer.
Future Oncol
; 10(7): 1187-202, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24947260
14.
Hypertension as predictive factor for bevacizumab-containing first-line therapy in metastatic breast and colorectal cancer in BRECOL (GEICAM/2011-04) study.
Clin Transl Oncol
; 2024 Apr 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38578537
15.
Obesity and survival in operable breast cancer patients treated with adjuvant anthracyclines and taxanes according to pathological subtypes: a pooled analysis.
Breast Cancer Res
; 15(6): R105, 2013 Nov 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-24192331
16.
Adjuvant docetaxel for high-risk, node-negative breast cancer.
N Engl J Med
; 363(23): 2200-10, 2010 Dec 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-21121833
17.
Palbociclib Rechallenge for Hormone Receptor-Positive/HER-Negative Advanced Breast Cancer: Findings from the Phase II BioPER Trial.
Clin Cancer Res
; 29(1): 67-80, 2023 01 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36165912
18.
Circulating miR-200c as a diagnostic and prognostic biomarker for gastric cancer.
J Transl Med
; 10: 186, 2012 Sep 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-22954417
19.
Circulating microRNAs: molecular microsensors in gastrointestinal cancer.
Sensors (Basel)
; 12(7): 9349-62, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-23012546
20.
Current Treatments for COVID-19: Application of Supercritical Fluids in the Manufacturing of Oral and Pulmonary Formulations.
Pharmaceutics
; 14(11)2022 Nov 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36365198